Matches in Nanopublications for { ?s ?p "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- NP27604.RAD2YhD8gDa8JzZfNIjFtqycfDrq2ykpw_ljKd0pGGc4M130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27604.RAD2YhD8gDa8JzZfNIjFtqycfDrq2ykpw_ljKd0pGGc4M130_provenance.
- NP27607.RAT221RxvPGwG4TtrtUlIJH-GRy783qV66fPqGApTjt8U130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27607.RAT221RxvPGwG4TtrtUlIJH-GRy783qV66fPqGApTjt8U130_provenance.
- NP27603.RAjXYyVWFW8IQxkG9sHJdRcxifrj1xkjprh3NnQwYVaV8130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27603.RAjXYyVWFW8IQxkG9sHJdRcxifrj1xkjprh3NnQwYVaV8130_provenance.
- NP27608.RALkqfl4SMnPRDlRaNdPXazXYKjRO3Vs3fGP5SpoI58gU130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27608.RALkqfl4SMnPRDlRaNdPXazXYKjRO3Vs3fGP5SpoI58gU130_provenance.
- NP27569.RASxEQtiOvoV9GQagqXhYYWfZATuzLRknk7TXXp2aRM2M130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27569.RASxEQtiOvoV9GQagqXhYYWfZATuzLRknk7TXXp2aRM2M130_provenance.
- NP27566.RAi7DkLrhfaEzl4Bb10e-JiR2EJqR_XksNcxi37tnHhNo130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27566.RAi7DkLrhfaEzl4Bb10e-JiR2EJqR_XksNcxi37tnHhNo130_provenance.
- NP27570.RAl2b_oEiwUjYg4p49HgUe3c08Wgf7WZufwcBK6QUWwGI130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27570.RAl2b_oEiwUjYg4p49HgUe3c08Wgf7WZufwcBK6QUWwGI130_provenance.
- assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP27565.RAGGKeMT6TTpIt9omISYVKMEtSjvqGGkgXhF0V2yEtaIc130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27565.RAGGKeMT6TTpIt9omISYVKMEtSjvqGGkgXhF0V2yEtaIc130_provenance.
- NP11652.RAG9S9WylyhhJeYR8tVeF_gULL9VSyRwS1XBFvkSBHQ9c130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11652.RAG9S9WylyhhJeYR8tVeF_gULL9VSyRwS1XBFvkSBHQ9c130_provenance.
- NP11654.RAG89LEmZDxr9tM5fFgrNXqgvxKQhs9zMMtsovM4NmgXg130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11654.RAG89LEmZDxr9tM5fFgrNXqgvxKQhs9zMMtsovM4NmgXg130_provenance.
- NP11651.RA2QllgMWJ1Zipy6yhNtaLPl_7DNEiVMNnuDgIYvxumJs130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11651.RA2QllgMWJ1Zipy6yhNtaLPl_7DNEiVMNnuDgIYvxumJs130_provenance.
- NP11653.RA9E5LdDL5u_9oQIuUHZMGMYt4bALRayTYDobuD0f5vYo130_assertion description "[Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11653.RA9E5LdDL5u_9oQIuUHZMGMYt4bALRayTYDobuD0f5vYo130_provenance.